Skip to content

TEMAPHARM

Active Private limited companyfounded 2019active for 7 yearsAvenue des Alouettes 11, 4121 NeupréKBO/BCE: BE 0727.468.425
TEMAPHARM
Financial year 2025
Follow ReportCompare

Annual accounts 2025

micro format, filed on 25-06-2026, 36 days before the deadline
€125,634
▲ 20.4%
€108,862
▲ 15.6%
€123,712
▲ 20.6%
€99,841
▲ 21.2%
37.2%
▼ 9.5 percentage points
0.65
▲ 0.15

Money flows

no detail for 2025

Balance sheet

balance sheet total €191,548 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

37.2%

Higher than 53% of 22,939 companies in 2025.

0.65

Higher than 18% of 22,068 companies in 2025.

44.4%

Higher than 95% of 22,218 companies in 2025.

TEMAPHARM Middle half of the sector 80% of the sector Micro accounts in retail trade (NACE 47)

Net result: top quarter · Equity: middle half · Balance sheet total: middle half · Working capital: bottom quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202120202019
Balance sheet: assets
20/58 191,548136,707135,994168,541135,733138,52228,868
21/28 131,124100,370108,804116,103128,909105,7189,312
22/27 131,124100,370108,804116,103128,909105,7189,312
22 90,31096,750103,190109,630113,75281,659-
23 02996981,0971,4961,895-
24 40,8143,3214,9175,37613,66122,1649,312
29/58 60,42436,33727,18952,4386,82432,80419,556
40/41 26,2442,3143,00128,1385,48425,0948,204
40 3,5942,3142,99528,1315,47825,0893,902
41 22,650077744,301
54/58 32,47932,70722,89822,90966,41310,419
490/1 1,7001,3161,2901,3911,3341,297933
Balance sheet: equity and liabilities
10/49 191,548136,707135,994168,541135,733138,52228,868
10/15 71,33063,93949,98526,02679,04862,53321,985
10/11 6,2006,2006,2006,2006,2006,2000
100 ------0
11 ------6,200
1100/10 ------6,200
14 65,13057,73943,78519,82672,84856,33315,785
17/49 120,21872,76886,008142,51556,68575,9896,883
17 26,901------
170/4 26,901------
42/48 93,31772,76885,639142,51556,51075,8146,883
42 7,558------
43 00010101085
430/8 00010101085
44 1,6881,2911,2566392,43025,3542,157
440/4 1,6881,2911,2566392,43025,3542,157
45 6,4717,3785,43710,3139,50312,2354,642
450/3 6,4715,0825,4379,2137,33312,2354,632
454/9 02,29501,1002,170010
47/48 77,60064,09978,946131,55344,56638,215-
492/3 -03690175175-
Income statement
70 ----102,093123,965-
76A 446------
9900 125,634104,339108,82977,58637,92562,46525,192
60/61 ----69,44864,919-
630 14,8508,43411,76314,98916,30511,8734,188
640/8 1,9221,7691,7061,1658292,834552
9901 108,86294,13695,36061,43220,79147,75820,452
75/76B --03-10
75 --03-10
65/66B 968160152921817036
65 968160152921817036
9903 107,89493,97695,20861,34320,61047,68920,416
67/77 22,90320,02221,24814,3654,0957,1414,632
9904 84,99173,95373,96046,97816,51640,54815,785
9905 84,99173,95373,96046,97816,51640,54815,785
Appropriation of the result
9906 142,730117,73993,785119,82672,84856,33315,785
14P 57,73943,78519,82672,84856,333--
694/7 77,60060,00050,000100,000---
694 75,00060,00050,000100,000---
695 2,600------
Document PDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 8 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 25-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 25-06-2026 2026-00198372 PDF
31-12-2024 micro format 20-06-2025 2025-00160913 PDF
31-12-2023 micro format 24-06-2024 2024-00155438 PDF
31-12-2022 micro format 23-06-2023 2023-00151448 PDF
31-12-2021 micro format 18-08-2022 2022-20298796 PDF
31-12-2020 micro format 31-08-2021 2021-60800519 PDF
31-12-2019 micro format 07-07-2020 2020-27000349 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202120202019
123,712102,570107,12376,42137,09659,63124,640
99,84182,38885,72261,96732,82052,42119,972
45,60404,4642,18339,496108,27913,500
-2279,809-1122,903-6,407-4,006-
-32,893-36,431-58,450-90,077-49,686-43,01012,672
----20.4%38.5%-
37.2%46.8%36.8%15.4%58.2%45.1%76.2%
0.650.500.320.370.120.432.84
1.691.141.725.480.721.220.31
119.2%115.7%148.0%180.5%20.9%64.8%71.8%
44.4%54.1%54.4%27.9%12.2%29.3%54.7%
over 100over 100over 100over 100over 100--
----20 days74 days-
----13 days143 days-

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€45,604€0€4,464€2,183€39,496
€14,850€8,434€11,763€14,989€16,305

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on TEMAPHARM

The operating result for 2025 is 16% higher than in 2024 and the highest since 2019. It is a recovery after the fall in 2024.

Debt's share of the balance-sheet total rises from 53.2% to 62.8%. Equity and debt are higher.

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure